EU Steps Up Antitrust Probe Of Drug Market

Law360, New York (May 15, 2008, 12:00 AM EDT) -- European antitrust investigators have reportedly intensified their probe of Europe's pharmaceutical companies to determine whether makers of brand-name drugs are preventing cheaper generic products from entering the market.

European Competition Commissioner Neelie Kroes is investigating whether drug companies are spending too much time and resources trying to block competitors from the market by extending drug patents and pursuing baseless litigation, rather than trying to develop new drugs, The New York Times reported.

The European Commission launched the inquiry on Jan. 15 with unannounced dawn raids on...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.